A Phase 2 Study to Evaluate Efficacy and Safety of KH607 Tablets in Woman With Postpartum Depression

Clinical trial NCT07096791 · COMPLETED

Trial details

NCT number: NCT07096791
Sponsor: Chengdu Kanghong Pharmaceutical Group Co., Ltd.
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Postpartum Depressive Disorder

Start date: 2025-09-02
Primary completion: 2026-04-24
Enrollment: 72

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.